NEXT Life Sciences

We’re proud to welcome Peter Barton Hutt, former Chief Counsel to the FDA and a pioneer of modern food and drug regulation, to the Advisory Board of NEXT Life Sciences. Peter shaped the FDA’s medical device guidance that continues to set the standard today. His expertise will be invaluable as we advance Plan A™, the first long-acting, reversible male contraceptive designed to bring balance and shared responsibility to family planning.

@planaformen is working toward a new era of male contraception, creating options that expand choice and reshape how couples approach family planning and sexual health. planaformen.com/posts/peter-ba…

“It’s like giving men a remote control for their choices.” A great description from Myles Sabiniano of Xraised - summing up what we’re developing with @planaformen

Our CEO, Dr. Darlene Walley, sat down with Myles to break down how @planaformen is flipping the script on birth control — with long-acting, reversible male contraception. xraised.com/videos/revolut…

This isn’t just a bold innovation—this is the future of reproductive health. @blksheepcapital is proud to be an early investor in @NextLifeScience , a company reshaping what male birth control could look like with @planaformen. Imagine a world where men have a simple, non-hormonal, reversible option—no more relying solely on female partners or permanent decisions. Takashi Y. lays it out perfectly in this article. The science is real. The demand is growing. And the market is massive. Disruption is coming to a space that’s been ignored for decades. I’m grateful to be backing founders like L.R. Fox who have the guts to challenge the norm and lead the way. linkedin.com/pulse/why-im-i… #Innovation #Biotech #MaleContraception #NextLifeSciences #Vasagel #FutureOfHealth #VC #EarlyStageInvesting

Last week, @erinbrodwin from @axios sat down for an exclusive interview with CEO Dr. Darlene Walley, where we were excited to announce that @NEXTLifeScience is now raising a $20M Series A to bring @planaformen — a male birth control option designed to be reversible and long-acting — to market.

With clinical trials kicking off in Australia this month and more plans for Canada in 2025, NEXT Life Sciences is now targeting a potential FDA submission in 2027 — a milestone that would make Plan A™ a game-changer for male contraception. 🔗 Read the full story on Axios: axios.com/pro/health-tec… #Innovation #Healthcare #MaleBirthControl #PlanA #ReproductiveHealth #SeriesA

This week on Healthcare Strategies, Dr. Darlene Walley, CEO of NEXT Life Sciences, sat down with Alivia Kaylor to introduce @planaformen — our reversible on-demand, long-acting male contraceptive in development - aiming for a 2027 launch. @pharmanewsintel

🔑 Key Highlights from the Discussion: - Flexible & Reversible: Blocks sperm with Vasalgel®, reversible in minutes. - High Demand: Vasectomy requests have spiked 1000% post-Roe v. Wade. - Affordable Access: Without insurance, the cost could approximate $8/month over 10 years, with the potential for full coverage by insurance in the future. - Global Potential: Plans to expand beyond the U.S. to Europe, Australia, and more.

With 85% of men aged 18-45 seeking new options, Plan A™ is poised to transform reproductive health for both men and women - balancing reproductive responsibility - and reshape the idea of family planning worldwide. 🌍 #MaleContraception #ReproductiveHealth #HealthcareInnovation buff.ly/DndMmLB

StartUp Health company @nextlifescience named Dr. Darlene Walley as CEO! Founder @LRFox_official will remain Executive Chairman to support the team, ensuring the right resources & setting long-term vision. ➡️ ow.ly/rjlC50UyXCG #HealthTransformer #HealthMoonshot

@LRFox_official shares: “Dr. Walley has already had incredible success in securing a clear pathway for Plan A with the FDA and it made sense for her to lead the entire organization to get our portfolio of products to market... Dr. Walley is known for her tremendous success as an executive in both big pharma and biotech startups where she has led companies specializing in drug development, manufacturing, and clinical research, and this rare combination puts her in an incredibly unique position to take all of our critical products to the world.” buff.ly/3BxeBPo

Today we are pleased to announce the promotion of Dr. Darlene Walley as the new CEO of NEXT Life Sciences! In addition, NEXT Life Sciences is also celebrating the joining of Dr Robert Dudley, founder and inventor of men’s health product AndroGel®, as our Chief Development Officer. @LRFox_official will remain as Founder and Executive Chairman and continue to support our team by ensuring we have the right resources and direction for the long-term vision of the company. Please join us in congratulating these members of our team!

In a new piece from @FortuneMagazine - Nina Ajemian interviewed @planaformen CEO, Dr. Darlene Walley as well as @malebcnow Executive Director, Heather Vahdat on their perspectives as the world prepares for a second Trump administration while male birth control options also continue getting closer to market.

“We’re in a time of transition, and the time is right for male contraception to really move out and get onto the market,” said MCI's Heather Vahdat. @NextLifeScience Dr. Darlene Walley continues, “We’re hoping that by giving the other half of the population the ability to participate in birth control that we can have a profound effect on pregnancies.” Read the piece in full at the link here: buff.ly/3Ozn6fN

StartUp Health company @nextlifescience, the maker of the male contraceptive Plan A™, has appointed Dr. Darlene R. Walley as the CEO of Plan A™ to spearhead and bring to market male birth control options. #HealthTransformer #HealthMoonshot ow.ly/LGy750TUTiB

We're honored to have the announcement of new @planaformen CEO Dr. Darlene Walley celebrated and featured in @FortuneMagazine MPW Daily with @_emmahinchliffe!

MPW Daily is the premier newsletter featuring the world’s most powerful women in business and leadership. Our team is beyond excited to have Dr. Walley leading our team as a true mover and shaker in the healthcare space. Join us again in celebrating Dr. Walley! buff.ly/4edbXM4 #planaformen #plana #malebirthcontrol #birthcontrol #malecontraceptive #malecontraception #healthcarenews #reproductivehealth #fortune #mpwdaily #mostpowerfulwomen #moversandshakers

We’re pleased to announce today that Dr. Darlene Walley, an expert with over 30 years of executive experience in life sciences, has been named the CEO of Plan A™ and that Peter Barton Hutt, former Chief Counsel to the FDA, has joined the Advisory Board for NEXT Life Sciences.

“We are thrilled to bring Dr. Walley on as the CEO of Plan A™ with her extensive background, expertise in biotech and pharma, and passion for bringing transformative products to market.” said @LRFox_official who will remain CEO of parent company NEXT Life Sciences, “I am also pleased to welcome Peter to our advisory Board, his exceptionally accomplished legal and policy career will help us advance our mission of bringing a new generation of accessible contraception to the market.”